Literature DB >> 22488247

Evolution of the B7 family: co-evolution of B7H6 and NKp30, identification of a new B7 family member, B7H7, and of B7's historical relationship with the MHC.

Martin F Flajnik1, Tereza Tlapakova, Michael F Criscitiello, Vladimir Krylov, Yuko Ohta.   

Abstract

The B7 family of genes is essential in the regulation of the adaptive immune system. Most B7 family members contain both variable (V)- and constant (C)-type domains of the immunoglobulin superfamily (IgSF). Through in silico screening of the Xenopus genome and subsequent phylogenetic analysis, we found novel genes belonging to the B7 family, one of which is the recently discovered B7H6. Humans and rats have a single B7H6 gene; however, many B7H6 genes were detected in a single large cluster in the Xenopus genome. The B7H6 expression patterns also varied in a species-specific manner. Human B7H6 binds to the activating natural killer receptor, NKp30. While the NKp30 gene is single-copy and maps to the MHC in most vertebrates, many Xenopus NKp30 genes were found in a cluster on a separate chromosome that does not harbor the MHC. Indeed, in all species so far analyzed from sharks to mammals, the number of NKp30 and B7H6 genes correlates well, suggestive of receptor-ligand co-evolution. Furthermore, we identified a Xenopus-specific B7 homolog (B7HXen) and revealed its close linkage to B2M, which we have demonstrated previously to have been originally encoded in the MHC. Thus, our study provides further proof that the B7 precursor was included in the proto MHC. Additionally, the comparative analysis revealed a new B7 family member, B7H7, which was previously designated in the literature as an unknown gene, HHLA2.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22488247      PMCID: PMC3709836          DOI: 10.1007/s00251-012-0616-2

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  65 in total

1.  A genomic view of immunology.

Authors:  A M Fahrer; J F Bazan; P Papathanasiou; K A Nelms; C C Goodnow
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

Review 2.  Several MHC-linked Ig superfamily genes have features of ancestral antigen-specific receptor genes.

Authors:  L Du Pasquier
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

3.  Crystal structure of human natural cytotoxicity receptor NKp30 and identification of its ligand binding site.

Authors:  M Gordon Joyce; Paul Tran; Marina A Zhuravleva; Jessica Jaw; Marco Colonna; Peter D Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-28       Impact factor: 11.205

4.  The chicken B locus is a minimal essential major histocompatibility complex.

Authors:  J Kaufman; S Milne; T W Göbel; B A Walker; J P Jacob; C Auffray; R Zoorob; S Beck
Journal:  Nature       Date:  1999-10-28       Impact factor: 49.962

5.  Major histocompatibility complex and immunoglobulin loci visualized by in situ hybridization on Xenopus chromosomes.

Authors:  M Courtet; M Flajnik; L Du Pasquier
Journal:  Dev Comp Immunol       Date:  2001-03       Impact factor: 3.636

6.  Cloning and characterization of Xenopus beta2-microglobulin.

Authors:  Rebecca Stewart; Yuko Ohta; Ralph R Minter; Terry Gibbons; Trudy L Horton; Pamela Ritchie; John D Horton; Martin F Flajnik; Martin D Watson
Journal:  Dev Comp Immunol       Date:  2005-01-24       Impact factor: 3.636

7.  Primordial linkage of β2-microglobulin to the MHC.

Authors:  Yuko Ohta; Takashi Shiina; Rebecca L Lohr; Kazuyoshi Hosomichi; Toni I Pollin; Edward J Heist; Shingo Suzuki; Hidetoshi Inoko; Martin F Flajnik
Journal:  J Immunol       Date:  2011-02-14       Impact factor: 5.422

8.  VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses.

Authors:  Li Wang; Rotem Rubinstein; Janet L Lines; Anna Wasiuk; Cory Ahonen; Yanxia Guo; Li-Fan Lu; David Gondek; Yan Wang; Roy A Fava; Andras Fiser; Steve Almo; Randolph J Noelle
Journal:  J Exp Med       Date:  2011-03-07       Impact factor: 14.307

9.  Structure of the human activating natural cytotoxicity receptor NKp30 bound to its tumor cell ligand B7-H6.

Authors:  Yili Li; Qian Wang; Roy A Mariuzza
Journal:  J Exp Med       Date:  2011-03-21       Impact factor: 14.307

10.  Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.

Authors:  D Pende; S Parolini; A Pessino; S Sivori; R Augugliaro; L Morelli; E Marcenaro; L Accame; A Malaspina; R Biassoni; C Bottino; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1999-11-15       Impact factor: 14.307

View more
  38 in total

1.  HHLA2 overexpression is a novel biomarker of malignant status and poor prognosis in gastric cancer.

Authors:  Li Wei; Liang Tang; Haiyan Chang; Song Huo; Yan Li
Journal:  Hum Cell       Date:  2019-09-24       Impact factor: 4.174

2.  Reconstitution of a ligand-binding competent murine NKp30 receptor.

Authors:  Stefanie Memmer; Sandra Weil; Joachim Koch
Journal:  Immunogenetics       Date:  2017-08-07       Impact factor: 2.846

3.  Inferring the "Primordial Immune Complex": Origins of MHC Class I and Antigen Receptors Revealed by Comparative Genomics.

Authors:  Yuko Ohta; Masanori Kasahara; Timothy D O'Connor; Martin F Flajnik
Journal:  J Immunol       Date:  2019-09-06       Impact factor: 5.422

4.  Structural insight into T cell coinhibition by PD-1H (VISTA).

Authors:  Benjamin T Slater; Xue Han; Lieping Chen; Yong Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  2020-01-09       Impact factor: 11.205

5.  A New B7:CD28 Family Checkpoint Target for Cancer Immunotherapy: HHLA2.

Authors:  Yanping Xiao; Gordon J Freeman
Journal:  Clin Cancer Res       Date:  2015-04-13       Impact factor: 12.531

Review 6.  A cold-blooded view of adaptive immunity.

Authors:  Martin F Flajnik
Journal:  Nat Rev Immunol       Date:  2018-07       Impact factor: 53.106

Review 7.  Coevolution of MHC genes (LMP/TAP/class Ia, NKT-class Ib, NKp30-B7H6): lessons from cold-blooded vertebrates.

Authors:  Yuko Ohta; Martin F Flajnik
Journal:  Immunol Rev       Date:  2015-09       Impact factor: 12.988

8.  HHLA2 is a member of the B7 family and inhibits human CD4 and CD8 T-cell function.

Authors:  Ruihua Zhao; Jordan M Chinai; Susan Buhl; Lisa Scandiuzzi; Anjana Ray; Hyungjun Jeon; Kim C Ohaegbulam; Kaya Ghosh; Aimin Zhao; Matthew D Scharff; Xingxing Zang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

9.  Wide Expression and Significance of Alternative Immune Checkpoint Molecules, B7x and HHLA2, in PD-L1-Negative Human Lung Cancers.

Authors:  Haiying Cheng; Alain Borczuk; Murali Janakiram; Xiaoxin Ren; Juan Lin; Amer Assal; Balazs Halmos; Roman Perez-Soler; Xingxing Zang
Journal:  Clin Cancer Res       Date:  2018-01-26       Impact factor: 12.531

10.  HHLA2 and TMIGD2: new immunotherapeutic targets of the B7 and CD28 families.

Authors:  Murali Janakiram; Jordan M Chinai; Aimin Zhao; Joseph A Sparano; Xingxing Zang
Journal:  Oncoimmunology       Date:  2015-04-14       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.